Abstract
Uropathogenic Escherichia coli (UPEC) cause the majority of uncomplicated urinary tract infections in humans. In the process of identifying candidate antigens for a vaccine, two methods for the identification of the UPEC surface proteome during growth in human urine were investigated. The first approach utilized a protease to 'shave' surface-exposed peptides from the bacterial cell surface and identify them by mass spectrometry. Although this approach has been successfully applied to a Gram-positive pathogen, the adaptation to Gram-negative UPEC resulted in cytoplasmic protein contamination. In a more direct approach, whole-cell bacteria were labeled with a biotin tag to indicate surface-exposed peptides and two-dimensional liquid chromatography-tandem mass spectrometry (2-DLC-MS/MS) was used to identify proteins isolated from the outer membrane. This method discovered 25 predicted outer membrane proteins expressed by UPEC while growing in human urine. Nine of the 25 predicted outer membrane proteins were part of iron transport systems or putative iron-regulated virulence proteins, indicating the importance of iron acquisition during growth in urine. One of the iron transport proteins identified, Hma, appears to be a promising vaccine candidate is being further investigated. The method described here presents a system to rapidly identify the outer membrane proteome of bacteria, which may prove valuable in vaccine development.
MeSH Terms
Bacterial Outer Membrane Proteins/analysis
Chromatography, Liquid/methods
Escherichia coli/chemistry,isolation & purification
Escherichia coli Proteins/analysis
Humans
Mass Spectrometry/methods
Proteome/analysis
Proteomics/methods
Urine/microbiology
Chemicals
Bacterial Outer Membrane Proteins
Escherichia coli Proteins
Proteome
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Walters Matthew S
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, United States.
Mobley Harry L T
References (27)
27 references, click to expand
-
Urologic diseases in America Project: analytical methods and principal findings.
J Urol. 2005 Mar;173(3):933-7
PMID: 15711342
-
The haemolysins of Escherichia coli.
J Pathol Bacteriol. 1963 Jan;85:197-211
PMID: 13989441
-
TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse.
Infect Immun. 2001 Oct;69(10):6179-85
PMID: 11553558
-
IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.
Infect Immun. 2002 Dec;70(12):7156-60
PMID: 12438401
-
Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli.
Infect Immun. 1989 Feb;57(2):446-51
PMID: 2643568
-
Virulence factors in Escherichia coli urinary tract infection.
Clin Microbiol Rev. 1991 Jan;4(1):80-128
PMID: 1672263
-
Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections.
J Clin Microbiol. 1987 Jan;25(1):146-9
PMID: 3539987
-
Molecular epidemiology of Escherichia coli mediated urinary tract infections.
Front Biosci. 2003 Jan 01;8:e235-44
PMID: 12456300
-
Comparison of SDS- and methanol-assisted protein solubilization and digestion methods for Escherichia coli membrane proteome analysis by 2-D LC-MS/MS.
Proteomics. 2007 Feb;7(4):484-493
PMID: 17309111
-
Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli.
J Bacteriol. 2007 May;189(9):3532-46
PMID: 17351047
-
A method for the comprehensive proteomic analysis of membrane proteins.
Nat Biotechnol. 2003 May;21(5):532-8
PMID: 12692561
-
Protease activity, secretion, cell entry, cytotoxicity, and cellular targets of secreted autotransporter toxin of uropathogenic Escherichia coli.
Infect Immun. 2006 Nov;74(11):6124-34
PMID: 16954394
-
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4
PMID: 12471157
-
Antibacterial vaccine design using genomics and proteomics.
Trends Biotechnol. 2001 May;19(5):181-8
PMID: 11301131
-
Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.
Infect Immun. 2007 Aug;75(8):3941-9
PMID: 17517861
-
Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection.
Mol Microbiol. 2009 Jan;71(1):79-91
PMID: 19019144
-
Urinary tract infection: self-reported incidence and associated costs.
Ann Epidemiol. 2000 Nov;10(8):509-15
PMID: 11118930
-
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.
Infect Immun. 1990 May;58(5):1281-9
PMID: 2182540
-
Expert system for predicting protein localization sites in gram-negative bacteria.
Proteins. 1991;11(2):95-110
PMID: 1946347
-
Aerobactin and alpha-hemolysin as virulence determinants in Escherichia coli isolated from human blood, urine, and stool.
J Infect Dis. 1990 Apr;161(4):794-6
PMID: 2181035
-
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome.
Nat Biotechnol. 2006 Feb;24(2):191-7
PMID: 16415855
-
Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli.
Infect Immun. 2001 Oct;69(10):6209-16
PMID: 11553562
-
Pore-forming cytolysins of gram-negative bacteria.
Mol Microbiol. 1991 Mar;5(3):521-8
PMID: 2046545
-
Proteomic analysis of the Escherichia coli outer membrane.
Eur J Biochem. 2000 May;267(10):2871-81
PMID: 10806384
-
Recurring urinary tract infection: incidence and risk factors.
Am J Public Health. 1990 Mar;80(3):331-3
PMID: 2305919
-
Technologies for bacterial surface proteomics.
Curr Opin Microbiol. 2006 Jun;9(3):320-9
PMID: 16679049
-
The application of mass spectrometry to membrane proteomics.
Nat Biotechnol. 2003 Mar;21(3):262-7
PMID: 12610573